These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 28360581)

  • 21. Risk of cardiovascular and cerebrovascular events and mortality in patients with migraine receiving prophylactic treatments: An observational cohort study.
    Hoffman V; Xue F; Ezzy SM; Yusuf A; Green E; Eisele O; Kurth T; Seeger JD
    Cephalalgia; 2019 Oct; 39(12):1544-1559. PubMed ID: 31195804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistence with migraine prophylactic treatment and acute migraine medication utilization in the managed care setting.
    Yaldo AZ; Wertz DA; Rupnow MF; Quimbo RM
    Clin Ther; 2008 Dec; 30(12):2452-60. PubMed ID: 19167603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tricyclic antidepressant therapy in headache].
    Magyar M; Csépány É; Gyüre T; Bozsik G; Bereczki D; Ertsey C
    Neuropsychopharmacol Hung; 2015 Dec; 17(4):177-82. PubMed ID: 26727721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study of amitriptyline and fluvoxamine in migraine prophylaxis.
    Bánk J
    Headache; 1994 Sep; 34(8):476-8. PubMed ID: 7960733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventive Oral Treatment of Episodic Migraine: An Overview.
    Ranganathan LN; Ramamurthy G; Kanthimathinathan S
    Neurol India; 2021; 69(Supplement):S51-S58. PubMed ID: 34003148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological approaches to migraine.
    Diener HCh
    J Neural Transm Suppl; 2003; (64):35-63. PubMed ID: 12830928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New and emerging prophylactic agents for migraine.
    Krymchantowski AV; Bigal ME; Moreira PF
    CNS Drugs; 2002; 16(9):611-34. PubMed ID: 12153333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acupuncture for the prevention of episodic migraine.
    Linde K; Allais G; Brinkhaus B; Fei Y; Mehring M; Vertosick EA; Vickers A; White AR
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD001218. PubMed ID: 27351677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An overview of the diagnosis and pharmacologic treatment of migraine.
    Capobianco DJ; Cheshire WP; Campbell JK
    Mayo Clin Proc; 1996 Nov; 71(11):1055-66. PubMed ID: 8917290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of paediatric headache.
    Lewis DW; Scott D; Rendin V
    Expert Opin Pharmacother; 2002 Oct; 3(10):1433-42. PubMed ID: 12387689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate.
    Mathew NT; Kailasam J; Meadors L
    Headache; 2002 Sep; 42(8):796-803. PubMed ID: 12390644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unveiling the relative efficacy, safety and tolerability of prophylactic medications for migraine: pairwise and network-meta analysis.
    He A; Song D; Zhang L; Li C
    J Headache Pain; 2017 Dec; 18(1):26. PubMed ID: 28220376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topiramate as an adjunctive treatment in migraine prophylaxis.
    Martínez HR; Londoño O; Cantú-Martínez L; del Carmen Tarín L; Castillo CD
    Headache; 2003; 43(10):1080-4. PubMed ID: 14629243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug safety and tolerability in prophylactic migraine treatment.
    Vécsei L; Majláth Z; Szok D; Csáti A; Tajti J
    Expert Opin Drug Saf; 2015 May; 14(5):667-81. PubMed ID: 25676133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overview of diagnosis and treatment of migraine.
    Silberstein SD; Lipton RB
    Neurology; 1994 Oct; 44(10 Suppl 7):S6-16. PubMed ID: 7969947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Weight variations in patients receiving topiramate migraine prophylaxis in a tertiary care setting.
    Krymchantowski A; Tavares C
    MedGenMed; 2004 Jul; 6(3):48. PubMed ID: 15520672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: results from the second international burden of migraine study (IBMS-II).
    Blumenfeld AM; Bloudek LM; Becker WJ; Buse DC; Varon SF; Maglinte GA; Wilcox TK; Kawata AK; Lipton RB
    Headache; 2013 Apr; 53(4):644-55. PubMed ID: 23458496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Levetiracetam and sodium Valproate in migraine prophylaxis: A randomized placebo-controlled study.
    Sadeghian H; Motiei-Langroudi R
    Ann Indian Acad Neurol; 2015; 18(1):45-8. PubMed ID: 25745310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consensus of the Brazilian Headache Society (SBCe) for prophylactic treatment of episodic migraine: part II.
    Santos PSF; Melhado EM; Kaup AO; Costa ATNMD; Roesler CAP; Piovesan ÉJ; Sarmento EM; Theotonio GOM; Campos HC; Fortini I; Souza JA; Júnior JAM; Segundo JBA; Carvalho JJF; Speziali JG; Calia LC; Barea LM; Queiroz LP; Souza MNP; Figueiredo MRCF; Costa MENM; Peres MFP; Jurno ME; Peixoto PM; Kowacs PA; Rocha-Filho PAS; Filho PFM; Silva-Neto RP; Fragoso YD
    Arq Neuropsiquiatr; 2022 Sep; 80(9):953-969. PubMed ID: 36257618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible precipitation of migraine attacks with prophylactic treatment.
    Donnet A; Vuillaume De Diego E; Lanteri-Minet M
    Eur Neurol; 2009; 61(1):23-6. PubMed ID: 18948696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.